
NOTICIA
22.04.2026Resumen IA
China's Volume-Based Procurement Reshapes Pharmaceutical Market Dynamics
China's volume-based procurement policy, which mandates bulk drug purchases for public hospitals, is intensifying price competition for multinational pharmaceutical companies while creating more profitable channels for domestic biotech firms in the private market. Analysts note potential benefits for internet healthcare platforms, pharmacies, and private hospital services.
S
SCMP News